Increased asymmetric dimethylarginine level after antiepileptic drug treatment may be independent of the changes in plasma homocysteine level.
Oğuzhan
O
Oz
Mehmet
M
Yücel
Hakan
H
Akgün
Zeki
Z
Gökçil
Zeki
Z
Odabaşi
D000927:Anticonvulsants / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives*; D004827:Epilepsy / Q000235:genetics*; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D045102:Methylenetetrahydrofolate Dehydrogenase (NAD+) / Q000235:genetics*; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000235:genetics*; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*
D000927:Anticonvulsants; D006710:Homocysteine; D001120:Arginine; D045102:Methylenetetrahydrofolate Dehydrogenase (NAD+); D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008754:Methylenetetrahydrofolate Dehydrogenase (NADP)